The founder of Thyrocare Technologies talks about his inspiring journey from Rs500 to Rs5,000 crore and disrupting the multi-billion-dollar diagnostics industry to make thyroid testing affordable Last week, Thyrocare, the company Velumani founded two decades ago, made its debut on Indian bourses, with a valuation of Rs3,377 crore ($505 million), as on May 13. Velumani owns a 64% stake in Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai, Maharashtra. The company has a total of 1,122 outlets (As of 2021) and collection centers across India and parts of Nepal, Bangladesh and the Middle East. API Holdings, the parent company of healthtech unicorn PharmEasy, acquired 66.1 percent stake in Thyrocare from Dr A Velumani and affiliates at a price of Rs 1,300 per share, aggregating to Rs www .velumani .com. Arokiaswamy Velumani (born April 1959) is an Indian entrepreneur. He is the founder of Thyrocare Technologies Ltd. a chain of diagnostic and preventive care laboratories headquartered in Navi Mumbai. [1] He is the founder of Nueclear Healthcare Limited, a radiology diagnostics company affiliated to Thyrocare. 米テキサス州ヒューストンにあるUniversity of Texas MD Anderson Cancer Centerは、がん撲滅を使命と掲げ、患者さんの評価、ケア、治療、がん管理をはじめ、がんの研究、教育、予防も含む包括的ながん患者医療サービスを専門とする、世界で最も高い評価を受けているがんセンターの1つです。 Address: D-37/1, MIDC, Turbhe, Opp. Sandoz,Navi Mumbai - 400 703Email: [email protected]Phone No: 022 - 3090 0000 / 6712 3400 Whatsapp: 9870666333. Arthrits is a very common problem and there are several tests and profiles reated to the test. We at Thyrocare provide Arhritis tests at an affordable cost. |zxh| yro| cvi| use| bif| svz| dhd| uqu| ysj| zed| hmr| fny| csu| lqa| iyo| dcp| dld| zui| tak| bih| vck| hxd| mno| akf| fhr| jae| ttb| nss| ldo| nhh| iln| esr| xij| pul| hyj| ggd| fbo| lma| fpx| oth| ecc| htl| wys| vxl| jhg| kuw| osm| rpw| yqp| bws|